tiprankstipranks
Clover Biopharmaceuticals Ltd. (HK:2197)
:2197
Hong Kong Market
2197
Clover Biopharmaceuticals Ltd.
RESEARCH TOOLSreports
Want to see HK:2197 full AI Analyst Report?

Clover Biopharmaceuticals Ltd. (2197) Income Statement

1 Followers

Clover Biopharmaceuticals Ltd. Income Statement

Last quarter (Q4 2025), Clover Biopharmaceuticals Ltd.'s total revenue was ¥246.81K, a decrease of -99.37% from the same quarter last year. In Q4, Clover Biopharmaceuticals Ltd.'s net income was ¥-98.51M. See Clover Biopharmaceuticals Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
¥ 3.41M¥ 38.42M¥ 39.26M¥ 0.00¥ 0.00
Gross Profit
¥ -23.85M¥ -672.94M¥ 24.24M¥ -475.64M¥ -66.27M
Operating Expenses
¥ 223.91M¥ 278.26M¥ 896.33M¥ 1.88B¥ 2.17B
Depreciation and Amortization
¥ 26.52M¥ 38.30M¥ 74.74M¥ 28.98M¥ 12.29M
EBITDA
¥ -221.24M¥ -916.54M¥ -45.07M¥ -2.37B¥ -2.23B
Operating Income
¥ -247.75M¥ -951.21M¥ -2.58B¥ -2.35B¥ -2.24B
Other Income/Expenses
¥ 47.97M¥ 47.78M¥ 2.44B¥ -100.70M¥ -3.78B
Pretax Income
¥ -199.78M¥ -903.43M¥ -138.54M¥ -2.45B¥ -6.02B
Net Income
¥ -199.78M¥ -903.43M¥ -138.54M¥ -2.45B¥ -6.02B
Per Share Metrics
Basic EPS
¥ -0.16¥ -0.72¥ -0.11¥ -2.22¥ -5.37
Diluted EPS
¥ -0.16¥ -0.72¥ -0.11¥ -2.22¥ -5.36
Weighted Average Shares Outstanding
 1.26B 1.25B 1.24B 1.10B 1.12B
Weighted Average Shares Outstanding (Diluted)
 1.26B 1.25B 1.24B 1.10B 1.12B
Currency in CNY

Clover Biopharmaceuticals Ltd. Earnings and Revenue History